162 related articles for article (PubMed ID: 37454137)
21. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.
Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P
Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863
[TBL] [Abstract][Full Text] [Related]
22. BRAF mutation status in gastrointestinal stromal tumors.
Hostein I; Faur N; Primois C; Boury F; Denard J; Emile JF; Bringuier PP; Scoazec JY; Coindre JM
Am J Clin Pathol; 2010 Jan; 133(1):141-8. PubMed ID: 20023270
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and therapeutic analysis of PDGFRA mutated gastrointestinal stromal tumor.
Huang W; Yuan W; Ren L; Liang H; Du X; Sun X; Fang Y; Gao X; Fu M; Sun Y; Shen K; Hou Y
Pathol Res Pract; 2022 Nov; 239():154138. PubMed ID: 36183438
[TBL] [Abstract][Full Text] [Related]
24. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.
Catic A; Kurtovic-Kozaric A; Sophian A; Mazur L; Skenderi F; Hes O; Rohan S; Rakheja D; Kogan J; Pins MR
BMC Med Genet; 2020 Oct; 21(1):202. PubMed ID: 33046021
[TBL] [Abstract][Full Text] [Related]
25. Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing.
Hechtman JF; Zehir A; Mitchell T; Borsu L; Singer S; Tap W; Oultache A; Ladanyi M; Nafa K
Genes Chromosomes Cancer; 2015 Mar; 54(3):177-84. PubMed ID: 25427437
[TBL] [Abstract][Full Text] [Related]
26. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
27. Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma.
Udager AM; Pan J; Magers MJ; Palapattu GS; Morgan TM; Montgomery JS; Weizer AZ; Hafez KS; Miller DC; Wolf JS; McHugh JB; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Am J Surg Pathol; 2015 Apr; 39(4):549-57. PubMed ID: 25602792
[TBL] [Abstract][Full Text] [Related]
28. Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
Capelli L; Petracci E; Quagliuolo V; Saragoni L; Colombo P; Morgagni P; Calistri D; Tomezzoli A; Di Cosmo M; Roviello F; Vindigni C; Coniglio A; Villanacci V; Catarci M; Coppola L; Alfieri S; Ricci R; Capella C; Rausei S; Gulino D; Amadori D; Ulivi P;
Eur J Surg Oncol; 2016 Aug; 42(8):1206-14. PubMed ID: 27265040
[TBL] [Abstract][Full Text] [Related]
29. Myxoid epithelioid gastrointestinal stromal tumor harboring an unreported PDGFRA mutation: report of a case and review of the literature.
Tajima S; Ohata A; Koda K; Maruyama Y
Int J Clin Exp Pathol; 2015; 8(5):5821-9. PubMed ID: 26191304
[TBL] [Abstract][Full Text] [Related]
30. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.
Belinsky MG; Skorobogatko YV; Rink L; Pei J; Cai KQ; Vanderveer LA; Riddell D; Merkel E; Tarn C; Eisenberg BL; von Mehren M; Testa JR; Godwin AK
Genes Chromosomes Cancer; 2009 Oct; 48(10):886-96. PubMed ID: 19585585
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls.
Torrence D; Xie Z; Zhang L; Chi P; Antonescu CR
Genes Chromosomes Cancer; 2021 Dec; 60(12):789-795. PubMed ID: 34398495
[TBL] [Abstract][Full Text] [Related]
32. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
33. Extra-gastrointestinal stromal tumor arising in the lesser omentum with a platelet-derived growth factor receptor alpha (PDGFRA) mutation: a case report and literature review.
Kanamori K; Yamagata Y; Honma Y; Date K; Wada T; Hayashi T; Otsuki S; Sekine S; Yoshikawa T; Katai H; Nishida T
World J Surg Oncol; 2020 Jul; 18(1):183. PubMed ID: 32703220
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Gao J; Li J; Li Y; Li Z; Gong J; Wu J; Liu N; Dong B; Qi C; Li J; Shen L
Oncotarget; 2016 May; 7(21):30241-9. PubMed ID: 26848617
[TBL] [Abstract][Full Text] [Related]
35. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
Joensuu H; Wardelmann E; Sihto H; Eriksson M; Sundby Hall K; Reichardt A; Hartmann JT; Pink D; Cameron S; Hohenberger P; Al-Batran SE; Schlemmer M; Bauer S; Nilsson B; Kallio R; Junnila J; Vehtari A; Reichardt P
JAMA Oncol; 2017 May; 3(5):602-609. PubMed ID: 28334365
[TBL] [Abstract][Full Text] [Related]
36. Application of BRAF V600E mutation analysis for the diagnosis of metanephric adenofibroma.
Mangray S; Breese V; Jackson CL; Lombardo K; Taliano R; Resnick M; Yakirevich E
Am J Surg Pathol; 2015 Sep; 39(9):1301-4. PubMed ID: 26274032
[No Abstract] [Full Text] [Related]
37. Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity.
Yi ES; Strong CR; Piao Z; Perucho M; Weidner N
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):157-61. PubMed ID: 15894928
[TBL] [Abstract][Full Text] [Related]
38. [Molecular features of metanephric adenoma and their values in differential diagnosis].
Wang X; Shi SS; Yang WR; Ye SB; Li R; Ma HH; Zhang RS; Lu ZF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):38-42. PubMed ID: 28072975
[No Abstract] [Full Text] [Related]
39. Clinicopathological and mutational characteristics of primary double mutant gastrointestinal stromal tumor: a single center study with review of the literature.
Yan J; He X; Shen C; Zou Y; Chen H; Tang Y
BMC Cancer; 2023 Mar; 23(1):217. PubMed ID: 36890498
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
